dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
Not yet recruiting · NCT06072326 · Registry updated 2025-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, type 1 diabetes mellitus, urinary system disorder | Not yet recruiting | Phase 2 | 2025-10-07 | NCT06072326 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biocity Biopharmaceutics Co., Ltd. | 5 |
| Juvenile Diabetes Research Foundation | 33 |
| University Medical Center Groningen | 213 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam University Academic Center | Amsterdam | Netherlands | 1 |
| Regionshospitalet Gødstrup | Herning | Denmark | 14 |
| Steno Diabetes Center Aarhus | Aarhus | Denmark | 5 |
| Steno Diabetes Center Copenhagen | Copenhagen | Denmark | 1 |
| Turku University Hospital | Turku | Finland | 27 |
| University Medical Center Groningen | Groningen | Netherlands | 2 |
| University of Helsinki | Helsinki | Finland | 1 |